Recombinant human plasma gelsolin (rhu-pGSN) in a patient hospitalized with critical COVID-19 pneumonia.
Clin Infect Pract
; 12: 100088, 2021 Nov.
Article
in English
| MEDLINE | ID: covidwho-1347544
ABSTRACT
Life-threatening COVID-19 pneumonia follows an exaggerated immune response to SARS-CoV-2. pGSN levels fall after SARS-CoV-2 infection. Rhu-pGSN improves outcomes in models of inflammation. In an intubated patient with critical COVID-19 pneumonia and progressive hypoxemia despite standard care, improvement became evident during rhu-pGSN infusions with full recovery within a few weeks.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
Language:
English
Journal:
Clin Infect Pract
Year:
2021
Document Type:
Article
Affiliation country:
J.clinpr.2021.100088
Similar
MEDLINE
...
LILACS
LIS